Literature DB >> 32066632

Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives.

Joana Carvalho1,2, Patricia Oliveira1,2, David Huntsman3,4,5, Carla Oliveira6,2,7, Janine Senz3,4, Celina São José1,2, Samantha Hansford3,4, Sara Pinto Teles1,2, Marta Ferreira1,2, Giovanni Corso8,9, Hugo Pinheiro2,10, Diana Lemos11, Valeria Pascale12, Franco Roviello12,13.   

Abstract

BACKGROUND: Familial intestinal gastric cancer (FIGC) remains genetically unexplained and without testing/clinical criteria. Herein, we characterised the age of onset and disease spectrum of 50 FIGC families and searched for genetic causes potentially underlying a monogenic or an oligogenic/polygenic inheritance pattern.
METHODS: Normal and tumour DNA from 50 FIGC probands were sequenced using Illumina custom panels on MiSeq, and their respective germline and somatic landscapes were compared with corresponding landscapes from sporadic intestinal gastric cancer (SIGC) and hereditary diffuse gastric cancer cohorts.
RESULTS: The most prevalent phenotype in FIGC families was gastric cancer, detected in 138 of 208 patients (50 intestinal gastric cancer probands and 88 unknown gastric cancer histology relatives), followed by colorectal and breast cancers. After excluding benign and intronic variants lacking impact in splicing, 12 rare high-quality variants were found exclusively in 11 FIGC probands. Only two probands carried potentially deleterious variants, but lacked somatic second-hits, weakly supporting the monogenic hypothesis for FIGC. However, FIGC probands developed gastric cancer at least 10 years earlier and carried more TP53 germline common variants than SIGC (p=4.5E-03); FIGC and SIGC could be distinguished by specific germline and somatic variant profiles; there was an excess of FIGC tumours presenting microsatellite instability (38%); and FIGC tumours displayed significantly more somatic common variants than SIGC tumours (p=4.2E-06).
CONCLUSION: This study proposed the first data-driven testing criteria for FIGC families, and supported FIGC as a genetically determined, likely polygenic, gastric cancer-predisposing disease, with earlier onset and distinct from patients with SIGC at the germline and somatic levels. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cancer: gastric; clinical genetics; diagnostics; evidence based practice; molecular genetics

Year:  2020        PMID: 32066632     DOI: 10.1136/jmedgenet-2019-106346

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  5 in total

1.  Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin.

Authors:  Alisa Förster; Frank Brand; Rouzbeh Banan; Robert Hüneburg; Christine A M Weber; Wiebke Ewert; Jessica Kronenberg; Christopher Previti; Natalie Elyan; Ulrike Beyer; Helge Martens; Bujung Hong; Jan H Bräsen; Andreas Erbersdobler; Joachim K Krauss; Martin Stangel; Amir Samii; Stephan Wolf; Matthias Preller; Stefan Aretz; Bettina Wiese; Christian Hartmann; Ruthild G Weber
Journal:  Acta Neuropathol       Date:  2021-04-30       Impact factor: 17.088

2.  Hereditary Diffuse Gastric Cancer-Update Based on the Current Consort Recommendations.

Authors:  Christoph Treese; Britta Siegmund; Severin Daum
Journal:  Curr Oncol       Date:  2022-03-30       Impact factor: 3.109

3.  Frequency of Positive Familial Criteria in Patients with Adenocarcinoma of the Esophageal-Gastric Junction and Stomach: First Prospective Data in a Caucasian Cohort.

Authors:  Jan Schölzchen; Christoph Treese; Peter Thuss-Patience; Alicja Mrózek; Beate Rau; Hendrik Seeliger; Dirk Hartmann; Lope Estevéz-Schwarz; Britta Siegmund; Denise Horn; Mani Nassir; Severin Daum
Journal:  Cancers (Basel)       Date:  2022-07-23       Impact factor: 6.575

Review 4.  Endoscopic Surveillance in Patients with the Highest Risk of Gastric Cancer: Challenges and Solutions.

Authors:  Jessica M Long; Jessica Ebrahimzadeh; Peter P Stanich; Bryson W Katona
Journal:  Cancer Manag Res       Date:  2022-10-10       Impact factor: 3.602

Review 5.  Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes.

Authors:  Irene Gullo; Federica Grillo; Luca Mastracci; Alessandro Vanoli; Fatima Carneiro; Luca Saragoni; Francesco Limarzi; Jacopo Ferro; Paola Parente; Matteo Fassan
Journal:  Pathologica       Date:  2020-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.